This illustration provided by Astrobotic Technology in 2024 depicts the Peregrine lunar lander on the surface of the moon. (Astrobotic Technology via AP)
Astronauts will have to wait until next year before flying to the moon and another few years before landing on it, under the latest round of delays announced by NASA on Tuesday.
The space agency had planned to send four astronauts around the moon late this year, but pushed the flight to September 2025 because of technical issues. The first human moon landing in more than 50 years also got bumped, from 2025 to 2026.
The news came barely an hour after a Pittsburgh company abandoned its own attempt to land its spacecraft on the moon because of a mission-ending fuel leak.
Launched on Monday as part of NASA's commercial lunar program, Astrobotic Technology's Peregrine lander was supposed to serve as a scout for the astronauts. A Houston company will give it a shot with its own lander next month.
NASA is relying heavily on private companies for its Artemis moon-landing program for astronauts, named after the mythological twin sister of Apollo.
Amazon blamed "regulatory hurdles" for calling off its proposed acquisition of robot vacuum maker iRobot. Not even a Roomba could clean up the deal's antitrust scrutiny.
To celebrate Flutter Entertainment's debut on the NYSE, FanDuel CEO Amy Howe shares her thoughts on the company's plans for growth, the future of online sportsbetting, and Super Bowl Sunday.
Investopedia's Caleb Silver shares thoughts on the upcoming Fed meeting, why individual investors are still slightly skeptical, and what he's looking for from mega cap tech earnings.
Season's greetings! Tax season, that is. January 29 is the first day you can file your tax return. We walk you through each step — plus a checklist you can download.
The Q-Collar helps protect athletes from impact-related concussions. Now, the U.S. Army is evaluating if the device could help reduce traumatic brain injury cased by blast weapons.
Co-founder and executive chairman of the board at Vaxxinity Lou Reese shares how the company is working to bring vaccines for chronic illnesses like heart disease and Parkinson’s to market with an eye for accessibility.
Mario Veneroso, Kingsview Asset Management Partner, weighs in on the latest economic data and whether the market is pricing in too many rate cuts for the coming year.
